甘露聚糖肽在治疗白细胞减少症中的临床应用  

Clinical Application of Mannatide in the Treatment of Leukopenia

作　　者：周容[1] 李雪林[1] 杜娟[1] 

机构地区：[1]四川省广安市广安区中医院急诊内科,广安638500

出　　处：《中国医药导刊》2014年第8期1239-1240,共2页Chinese Journal of Medicinal Guide

摘　　要：目的:观察甘露聚糖肽治疗白细胞减少症的临床疗效。方法:79例白细胞减少症患者随机分为试验组(52例)和对照组(27例),对照组服用地榆升白片,饭后12分钟内口服,3次/日,3片/次,试验组服用甘露聚糖肽胶囊,口服,10mg/次,3次/日,均连续服用8周。结果:试验组患者服药后大约7天开始起效,治疗结束时白细胞计数较治疗前升高1.16×109/L,临床有效率为96.15%。两组外周血白细胞计数、临床疗效比较具有统计学差异(P<0.05)。结论:应用甘露聚糖肽治疗白细胞减少症,其起效快,且临床疗效也优于地榆升白片。To observe the clinical efficacy of Mannatide in the treatment of patients with leukopenia.Methods：79 cases of leukopenia were randomly divided into treatment group （52 cases） and control group （27 cases）. The control group received Diyushengbai tablets, orally within 12 minutes after a meal, 3 times / day, 3 / times. The test group taking Mannatide capsules, oral, 10mg/ time, 3 times / day. Both took eight weeks.Results：Treatment group were beginning taking effect approximately seven days after, white blood cell count elevated 1.16 × 109/L at the end of treatment than before. The clinical effective rate of treatment group was 96.15%. White blood cell count and clinical efficacy of two groups had significant difference （P〈0.05）.Conclusion：The application of Mannatide in the treatment of leukopenia had a rapid onset, the clinical efficacy was better than Diyushengbai tablets.

关 键 词：甘露聚糖肽 白细胞减少症 地榆升白片 

分 类 号：R557.1[医药卫生—血液循环系统疾病]